Plasmodium falciparum -Continued had been in East Africa and who were taking, or had recently completed, chloroquine chemoprophylaxis (5-10 mg/kg/week) {7,11,12). In each case the blood chloroquine concentra tion, measured at the time of diagnosis (before treatment), established failure of chloroquine prophylaxis against these P. falciparum strains from East Africa.
The present case fits this pattern of chloroquine-prophylaxis failure. The chloroquine con centration, 114 ppb, is consistent with a history of appropriate prophylaxis and would be ex pected to suppress chloroquine-sensitive strains of P. falciparum (13).
In the past year, CDC has received reports of 8 other U.S. travelers to East Africa, in addi tion to the present case, who have experienced failure of chloroquine therapy or prophylaxis associated with documented P. falciparum infection. The countries now known to be involved are Kenya, Madagascar, Tanzania, and the Comoro Islands. The epidemiologic and parasitologic features of these cases are consistent with the pattern established in the other reported cases. However, because of delayed notification, not all critical elements of case descriptions, such as quantification of blood chloroquine, have been available.
At present, chloroquine continues to be a relatively safe and effective antimalarial for prophylaxis in East Africa. Since the prevalence of chloroquine-resistant P. falciparum in that area remains unknown and the degree of resistance is low, it is unclear whether current recommendations for chloroquine prophylaxis for travelers to East Africa need to be altered.
CDC is maintaining intensive surveillance for failure of chloroquine prophylaxis and treatment.
As additional information on this evolving situation becomes available, it will be reported.
CDC can provide in vitro drug-sensitivity testing and determine blood chloroquine concentra tions and would like to receive reports through state health departments of all suspected cases of chloroquine-resistant P. falciparum malaria acquired in Africa.
Current Trends
The Cost of One Rabid Dog -California On May 10, 1 980, a dog in Yuba County, California, was placed under observation after it bit 3 persons in a parking lot in the Olivehurst area. Because the dog appeared ill, it was killed, and tissues were tested and found positive for rabies on May 12. The subsequent investiga tion by Sutter-Yuba County Health Department personnel eventually resulted in the identifica tion of 70 persons, who received antirabies prophylaxis because of known or probable expo sure to the dog. Because investigators found that only 20% of the dogs and cats in the area had up-to-date vaccinations, special clinics were held in which 2,000 dogs were vaccinated; over 300 unclaimed dogs and cats were destroyed.
No persons or other animals were known to develop rabies as a result of this episode. How ever, the costs generated by this single rabid dog were estimated as: $92,650 for human an tirabies treatment, $4,190 for animal vaccination and veterinary services, and $8,950 for health-department and animal-control programs. The total cost of the episode was $105,790, or over $1,500 per person treated, not including lost work time, patient travel time, and costs of the 6 months' quarantine imposed on animals exposed to the rabid dog. A standard questionnaire was administered to the 1 5 persons, and food-specific attack rates implicated a zucchini cake as the common source of illness. The preparer of the cake, when questioned, admitted to the possibility of having inadvertently added marijuana to the recipe.
Microscopic examination of the zucchini cake showed cystolithic hairs (indicating plant cell-wall material), and a Duquenois-Levine test for cannabinoids confirmed the presence of marijuana in the cake. Editorial Note: A similar episode occurred in Colorado in 1978 in which 9 of 22 persons ex posed to marijuana in a bundt cake became ill( 7).
The symptoms described in the present outbreak are physiologically consistent with the effects of marijuana (2) . Tolerance to marijuana is well substantiated (3), and persons with repeated experience with the substance may have less pronounced physiologic (as well as psychologic) changes. Furthermore, persons who deliberately use marijuana for its psycho logic effects would experience and interpret such "symptoms" differently than described herein.
Marijuana, obtained from the hemp plant Cannabis sativa, is a complex mixture of over 400 chemicals. Delta-9-tetrahydrocannabinol (THC) is the major source of psychoactivity, but there are numerous cannabinoids that have biological activity. THC is 3-5 times as potent when inhaled as when ingested, because it is insoluble in water at room temperature and its composition is altered by the acid pH of the stomach. However, the fatty substances in baked foods facilitate absorption and the production of a pharmacologically active dose (3). Be cause the composition of marijuana is varied and the absorption is incomplete, the onset and duration of symptoms may vary also. Symptoms usually begin from 1/2 to 1 hour after ingestion and last from 3 to 6 hours (4). THC leaves the blood rapidly but is taken up by the tissues. Complete elimination of a dose may take up to 30 days. ,_ . , "". These 2 episodes of marijuana-associated illness suggest that marijuana might be consid ered as a toxin when food-borne outbreaks are being investigated.
Measles -Continued
As of October 10, 1 6 confirmed cases of measles had occurred in an outbreak in White County, Arkansas ( Figure 2) ; 13 patients were students at Harding University, and 3 were con tacts of students. The outbreak was traced to four university students who had visited Hondu ras from August 2 to 16, 1981. The measles immunity status of these 4 students had not been assessed before their trip. None of the 4 had documented evidence of having received live-measles vaccine on or after their first birthday or of having a physician-documented his tory of measles disease. Two of these students were infected with measles in Honduras and had onset of rash on August 1 7 and August 24, respectively. The other 2 students, siblings of the second patient, had acquired measles from their sister after returning to the United
States. Spread to 9 other students resulted from contact with infected persons in dormitories, classrooms, and recreational settings.
The 3 cases in persons who were not university students resulted from contact with ill stu dents who were seeking medical attention. These cases occurred in a hospital employee, a preschool child, and a pregnant woman. The pregnant woman went into labor, presumably as a result of her measles, and had a premature infant who was otherwise healthy.
The diagnosis of measles was delayed for the first four patients, because they were initially hospitalized for suspected typhoid fever. After the outbreak was reported to the state health Measles -Continued 3 Q001 00128 2021 cans returning from travel abroad (1) . This outbreak raises the question of the need for child ren and young adults to be adequately protected against measles before traveling abroad (7).
It also shows that physicians should consider the diagnosis of measles for persons with a his tory of recent travel abroad who have febrile illness accompanied by rash.
Participation by college students in vaccination clinics during outbreaks has usually been low, although controlled studies have shown that there is no increased risk of serious side ef fects from measles vaccination for young adults (2, 3) . Consequently, the high degree of par ticipation by students in the voluntary vaccination clinics at Harding University is noteworthy.
Several college-based measles outbreaks have been described in recent years (2-4). Con tinued reporting of outbreaks such as the one discussed above has led the Immunization Prac tices Advisory Committee to emphasize the need for college officials to strongly consider requiring documented evidence of immunity for entering students (5).
